<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03327389</url>
  </required_header>
  <id_info>
    <org_study_id>4-2017-0767</org_study_id>
    <nct_id>NCT03327389</nct_id>
  </id_info>
  <brief_title>Effect of Dexmedetomidine on Renal Function and Delayed Graft Function After Kidney Transplantation</brief_title>
  <official_title>Effect of Dexmedetomidine on Renal Function and Delayed Graft Function After Kidney Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to elucidate the effect of dexmedetomidine on renal function and
      delayed graft function after kidney transplantation
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Dexmedetomidine group
Control group</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>participants, investicator, outcome assessors will be blinded for group allocation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Serum creatinine level</measure>
    <time_frame>postoperative 7 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of delayed graft function</measure>
    <time_frame>7 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of serum creatinine</measure>
    <time_frame>maximum 30 days before surgery, 1 hour after surgery, 1 day, 2 day, 3 day, 5 day, 7 day after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood urea nitrogen (BUN)</measure>
    <time_frame>maximum 30 days before surgery, 1 hour after surgery, 1 day, 2 day, 3 day, 5 day, 7 day after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cystatin C</measure>
    <time_frame>maximum 30 days before surgery, 1 hour after surgery, 1 day, 2 day, 3 day, 5 day, 7 day after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neutrophil gelatinase-associated lipocalin (NGAL)</measure>
    <time_frame>maximum 30 days before surgery, 1 hour after surgery, 1 day, 2 day, 3 day, 5 day, 7 day after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urine output</measure>
    <time_frame>during surgery, 1 day, 2 day, 3 day, 4 day, 5 day, 6 day, 7 day after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fluid intake(intraoperative intake and output measured by the amount of fluid(crystalloid/colloid)(mL) and blood administered(mL))</measure>
    <time_frame>during surgery, 1 day, 2 day, 3 day, 4 day, 5 day, 6 day, 7 day after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>kidney ultrasound</measure>
    <time_frame>1 week, 1 month after surgery, if possible</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inflammatory mediator (IL-18, Il-1b) level</measure>
    <time_frame>immediately after induction, immediately after vessel clamp, immediately after reperfusion, 1hour after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">104</enrollment>
  <condition>Kidney Transplantation</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine (Group D)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine infusion during surgery Dexmedetomidine was infused at a rate of 0.4 μg/kg/h starting immediately after anesthetic induction and continued until skin closure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control (Group C)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.9% NaCl infusion during surgery 0.9% NaCl was infused at a rate of 0.4 μg/kg/h starting immediately after anesthetic induction and continued until skin closure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>dexmedetomidine was infused at a rate of 0.4 μg/kg/h starting immediately after anesthetic induction and continued until skin closure.</description>
    <arm_group_label>Dexmedetomidine (Group D)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>0.9% NaCl was infused at a rate of 0.4 μg/kg/h starting immediately after anesthetic induction and continued until skin closure</description>
    <arm_group_label>Control (Group C)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. adult (20-80 years old)

          2. patients undergoing elective kidney transplantation

        Exclusion Criteria:

          1. emergency surgery

          2. severe sinus bradycardia (&lt;50 beats per min [bpm])

          3. second-degree or third-degree heart block

          4. decreased heart function (EF &lt;30%)

          5. acute myocardial ischemia

          6. serious hepatic dysfunction (Child-Pugh class C)

          7. patients with known or suspected severe adverse reactions to DEX (or clonidine)

          8. treatment with clonidine or dexmedetomidine in the past 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jin Ha Park, MD</last_name>
    <phone>82-2-2228-2420</phone>
    <phone_ext>82-2-2227-7897</phone_ext>
    <email>realsummer@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin Ha Park, MD</last_name>
      <phone>82-2-2228-2420</phone>
      <phone_ext>82-2-2227-7897</phone_ext>
      <email>realsummer@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2017</study_first_submitted>
  <study_first_submitted_qc>October 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2017</study_first_posted>
  <last_update_submitted>November 26, 2017</last_update_submitted>
  <last_update_submitted_qc>November 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delayed Graft Function</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

